Skip to main content

Table 2 Odd ratios for the prevalence of metabolic syndrome according to rheumatoid factor quartiles

From: Association between rheumatoid factor and metabolic syndrome in general population

   

Q2

Q3

Q4

P for trend

The revised NCEP ATP III criteria

Model 1

OR

1.219 (1.105,1.346)

1.678 (1.522,1.850)

1.865 (1.691,2.056)

 < 0.001

P

 < 0.001

 < 0.001

 < 0.001

 

Model 2

OR

1.211 (1.095,1.339)

1.661 (1.505,1.834)

1.825 (1.647,2.023)

 < 0.001

P

 < 0.001

 < 0.001

 < 0.001

 

Model 3

OR

1.268 (1.144,1.405)

1.308 (1.180,1.450)

1.420 (1.275,1.581)

 < 0.001

P

 < 0.001

 < 0.001

 < 0.001

 

Model 4

OR

1.197 (1.077,1.329)

1.135 (1.021,1.261)

1.175 (1.052,1.313)

0.002

P

0.001

0.019

0.004

 

The IDF criteria

Model 1

OR

1.373 (1.219,1.547)

1.654 (1.472,1.858)

3.100 (2.773,3.465)

 < 0.001

P

 < 0.001

 < 0.001

 < 0.001

 

Model 2

OR

1.312 (1.162,1.482)

1.587 (1.410,1.787)

2.697 (2.397,3.035)

 < 0.001

P

 < 0.001

 < 0.001

 < 0.001

 

Model 3

OR

1.406 (1.242,1.590)

1.437 (1.272,1.624)

2.355 (2.085,2.660)

 < 0.001

P

 < 0.001

 < 0.001

 < 0.001

 

Model 4

OR

1.291 (1.137,1.466)

1.151 (1.014,1.306)

1.776 (1.566,2.015)

 < 0.001

P

 < 0.001

0.029

 < 0.001

 
  1. Model 1: unadjusted; Model 2: adjusted for age and sex; Model 3: adjusted for age, sex, aspartate aminotransferase, alanine aminotransferase, and gamma-glutamyl transpeptidase; Model 4: adjusted for age, sex, aspartate aminotransferase, alanine aminotransferase, gamma-glutamyl transpeptidase and high sensitivity-C reactive protein
  2. NCEP, National Cholesterol Education Program; ATP, Adult Treatment Panel; IDF, International Diabetes Federation